5 Key Takeaways
-
1
Geographic atrophy (GA) is a severe form of age-related macular degeneration (AMD) that causes progressive vision loss.
-
2
New GA drugs require updates in coding and billing practices, with pegcetacoplan transitioning to HCPCS code J2781 on October 1, 2023.
-
3
Billing units for GA drugs are based on dosage; pegcetacoplan is 15 units per 15 mg, while avacincaptad pegol is 20 units per 2 mg.
-
4
The JW modifier is required for discarded drug amounts, while the JZ modifier is for when no drug is wasted, effective July 1, 2023.
-
5
Good Days, a nonprofit aiding treatment costs, has exhausted funding for 2025, impacting patients' access to GA treatments and increasing provider burdens.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


